Sign In
Buy ASPI
$7.55
-0.780 (-9.36%)
At Close: Jun 03, 2026
NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company")
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Connect
05:20pm, Tuesday, 13'th May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company")
ASP Isotopes: Proposed Listing And Growth Initiatives To Provide Impetus Into 2026
12:15pm, Thursday, 01'st May 2025
ASP Isotopes Inc.'s secondary listing on the Johannesburg Stock Exchange is expected to enhance liquidity, diversify the shareholder base, and position the company for growth. ASPI's proprietary techn
ASP Isotopes Inc. Announces Changes in Boards of ASP Isotopes Inc. and Quantum Leap Energy LLC
08:00am, Tuesday, 15'th Apr 2025
- Highly respected South African Businessman, Mr Sipho Maseko, former CEO of Telkom SA Soc Ltd and MD of Vodacom SA, Has Joined the Board of Directors of ASP Isotopes Inc.
NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company"
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company"
ASP Isotopes Inc. (ASPI) Q4 2024 Earnings Conference Call Transcript
03:37pm, Tuesday, 01'st Apr 2025
ASP Isotopes Inc. (NASDAQ:ASPI ) Q4 2024 Earnings Conference Call April 1, 2025 10:00 AM ET Company Participants Nick Lawson - IR Paul E. Mann - Chairman and CEO Hendrik Strydom - Chief Technology Off
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company"
- Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis' Pluvicto.
ASP Isotopes Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Webinar
12:00pm, Monday, 31'st Mar 2025
WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), announced that it will release its fourth quarter and fiscal year 2024 financial
NEW YORK CITY, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Stockholders to Inquire about Securities Investigation
10:00am, Tuesday, 25'th Mar 2025
NEW YORK CITY, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company
NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company
NEW YORK CITY, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Connect
10:00am, Sunday, 16'th Mar 2025
NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company
